Racial Differences in Clinical Features and Comorbidities in Ankylosing Spondylitis in the United States

J Rheumatol. 2020 Jun 1;47(6):835-838. doi: 10.3899/jrheum.181019. Epub 2019 Sep 1.

Abstract

Objective: To examine racial differences of clinical features, medication usage, and comorbidities of patients with ankylosing spondylitis (AS) in the United States.

Methods: In the Explorys database, 28,520 patients with AS were identified. Data were stratified by 2 rheumatology visits, race, sex, clinical characteristics, medication use, and comorbidities. Datasets were recorded as proportions, which were compared using chi-square test (p < 0.05).

Results: Of the 10,990 patients with AS, 8% were African Americans and had elevated erythrocyte sedimentation rate and C-reactive protein, and high frequency of anterior uveitis, hypertension, diabetes, depression, and heart disease.

Conclusion: African Americans with AS in the United States have high disease activity and comorbidities compared to whites.

Keywords: AFRICAN AMERICANS; ANKYLOSING SPONDYLITIS; DISEASE SEVERITY; RACIAL FACTORS.

MeSH terms

  • C-Reactive Protein
  • Comorbidity
  • Humans
  • Race Factors
  • Severity of Illness Index
  • Spondylitis, Ankylosing* / epidemiology
  • United States / epidemiology

Substances

  • C-Reactive Protein